Within a biochemical clinical viewpoint, Relafen 750 (Naproxen) exhibits particular characteristics . It functions primarily as a non-copyrightal medication , largely inhibiting cyclooxygenase-2 (COX-2), an catalyst involved in prostaglandin formation. This focused inhibition generates decreased inflammation and discomfort , delivering therapeutic